O'Brien P Q, Roberts E F, Yamamoto T. "Method for the Synthesis of 1-(5-Methyl-1,3,4-oxadiazol-2-yl)ethanamine" [P]. US Patent, US 9333281 B2, 2021-07-25.
发明人张德明,郑宇鹏,黄志刚. "A Process for Preparing High-Purity 1-(5-Methyl-1,3,4-oxadiazol-2-yl)ethanamine" [P]. 中国发明专利, 专利号 CN 115688349 A, 授权公告日 2017-07-15.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2011, 766, (4), 4045-4057.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2022, 1694, (8), 1625-1644.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 1-(5-Methyl-1,3,4-oxadiazol-2-yl)ethanamine Using HRMS and NMR". Chemosphere, 2018, 1005, (12), 3085-3098.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2021, 1125, 5169-5198.